Archer Investment Corp Tekla Life Sciences Investors Transaction History

Archer Investment Corp

$375 Billion
Q4 2024

Shares

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 13, 2020	SELL	$16.71 - $19.06 $52,803 - $60,229	-3,160 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$14.22 - $18.38 $20,960 - $27,092	1,474 Added 87.43%	3,160 $56,000
Q1 2020 May 07, 2020	BUY	$12.22 - $17.99 $20,602 - $30,331	1,686 New	1,686 $25,000

Others Institutions Holding HQL

# of Institutions

79

Shares Held

9.65M

Call Options Held

0

Put Options Held

0

Saba Capital Management, L.P. New York, NY

3.43M
Shares

$44.7 Million
1.11% of portfolio
Penserra Capital Management LLC Orinda, CA

828K
Shares

$10.8 Million
0.2% of portfolio
Karpus Management, Inc. Pittsford, NY

490K
Shares

$6.38 Million
0.23% of portfolio
Sit Investment Associates Inc Minneapolis, MN

417K
Shares

$5.43 Million
0.12% of portfolio
Absolute Investment Advisers LLC

400K
Shares

$5.21 Million
0.67% of portfolio

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Archer Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Archer Investment Corp with notifications on news.